215 related articles for article (PubMed ID: 28755241)
1. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
Chang ET; Lau EC; Mowat FS; Teta MJ
Cancer Causes Control; 2017 Sep; 28(9):971-979. PubMed ID: 28755241
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic radiation for lymphoma: risk of malignant mesothelioma.
Teta MJ; Lau E; Sceurman BK; Wagner ME
Cancer; 2007 Apr; 109(7):1432-8. PubMed ID: 17315168
[TBL] [Abstract][Full Text] [Related]
3. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
4. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
5. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
Ali S; Olszewski AJ
Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
[TBL] [Abstract][Full Text] [Related]
6. Incidence of malignant pleural mesothelioma after thoracic radiotherapy.
Neugut AI; Ahsan H; Antman KH
Cancer; 1997 Sep; 80(5):948-50. PubMed ID: 9307196
[TBL] [Abstract][Full Text] [Related]
7. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
8. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
9. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database.
Farioli A; Ottone M; Morganti AG; Compagnone G; Romani F; Cammelli S; Mattioli S; Violante FS
Cancer Med; 2016 May; 5(5):950-9. PubMed ID: 26860323
[TBL] [Abstract][Full Text] [Related]
11. Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers.
Kim CJ; Freedman DM; Curtis RE; Berrington de Gonzalez A; Morton LM
Leuk Lymphoma; 2013 Aug; 54(8):1691-7. PubMed ID: 23193978
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma.
Chirieac LR; Barletta JA; Yeap BY; Richards WG; Tilleman T; Bueno R; Baldini EH; Godleski J; Sugarbaker DJ
J Clin Oncol; 2013 Dec; 31(36):4544-9. PubMed ID: 24248693
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma.
Rossi C; Jégu J; Mounier M; Dandoit M; Colonna M; Daubisse-Marliac L; Trétarre B; Ganry O; Guizard AV; Bara S; Bouvier V; Woronoff AS; Monnereau A; Casasnovas O; Velten M; Troussard X; Maynadié M
Leuk Lymphoma; 2015; 56(10):2876-82. PubMed ID: 25641432
[TBL] [Abstract][Full Text] [Related]
14. Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis.
Boukheris H; Ron E; Dores GM; Stovall M; Smith SA; Curtis RE
Cancer; 2008 Dec; 113(11):3153-9. PubMed ID: 18823043
[TBL] [Abstract][Full Text] [Related]
15. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
16. Changes in the use of radiation therapy for early classical Hodgkin lymphoma in adolescents and young adults: implications for survival and second malignancies.
Xavier AC; Costa LJ
Leuk Lymphoma; 2015; 56(8):2339-43. PubMed ID: 25393805
[TBL] [Abstract][Full Text] [Related]
17. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database.
Farioli A; Violante FS; Mattioli S; Curti S; Kriebel D
Cancer Causes Control; 2013 Aug; 24(8):1535-45. PubMed ID: 23702885
[TBL] [Abstract][Full Text] [Related]
18. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
19. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
[TBL] [Abstract][Full Text] [Related]
20. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]